Pfizer Ltd

Pfizer Ltd

PFIZER

 5,172.36
 81.29
1.60%
Healthcare
 0.00
(%)1D
Updated: 12 Sep 2025, 03:31:17 pm IST
Stock Score
Open Price
 5,128.07
Prev. Close
 5,091.07
 5,076.37
Day Low
 5,238.13
Day High

 3,718.77
52 Week Low
 6,086.54
52 Week High

Quick Bite

Price To Earnings Ratio

30.83

Sector PE

68.10

PB Ratio

5.61

Sector PB

5.99

EPS

167.78

Dividend Yield

4.12

Today's Volume

30.819 K

5 Day Avg. Volume

16.751 K

PEG Ratio

0.79

Market Cap.

₹ 23,410.00 Cr.

News & Events

About Pfizer Ltd

Pfizer Limited (Pfizer) is an India-based multinational pharmaceutical company focusing on therapy in four business categories, namely, Vaccines, Hospitals, Internal Medicine, and Inflammation and Immunology. Pfizer's Vaccines Division focuses on Prevenar 13, a Pneumococcal Conjugate Vaccine approved for administering to individuals of all ages against pneumococcal disease, an infection caused by streptococcus pneumoniae bacteria. Internal Medicine portfolio includes approximately 17 specialties and seven therapy areas, including respiratory, multivitamin and multimineral, gastrointestinal, pain, neuroscience, cardiovascular and women's healthcare. Pfizer Hospital Business Unit focuses on providing advanced anti-infectives to institutions such as hospitals and nursing homes. Inflammation and Immunology focuses on discovering and developing novel therapeutics for chronic autoimmune diseases. Its brands include Prevenar13, CorexDX, Dolonex, Enbrel, Becosules and Folvite, among others.

Pfizer Ltd Share Price

Pfizer Limited is an Indian pharmaceutical company. The company's field of activity is the production, distribution, trade and export of medicines. The company has its own manufacturing facility in Goa. The company has several independent contract/third party manufacturers in India. Its product portfolio includes vaccines, anti-infective, cardiac, pain, maternal nutrition, gastrointestinal, anti-pregnancy, anti-inflammatory, anti-nutritional and anti-immune vaccines, and respiratory vaccines. The company's vaccine business focuses on Prevenar 13, a pneumococcal conjugate vaccine administered to infants six weeks of age and older as part of the primary immunisation program, infants, adolescents, adults and the elderly. Its inflammation and immunology portfolio includes two advanced therapies serving patients suffering from chronic immune-related diseases such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis and ulcerative colitis.

Pfizer Ltd FAQs

How to Buy Pfizer Ltd Share?

up
To purchase Pfizer Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Pfizer Ltd (ticker symbol: PFIZER) on the trading platform provided by your broker and purchase the shares.

What's Pfizer Ltd share price today?

up
The stock price of Pfizer Ltd as of 15 Sep 2025 is ₹5,172.36

What is the Market Cap of Pfizer Ltd?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 15 Sep 2025, Pfizer Ltd (ticker symbol: PFIZER) has a market capitalisation of approximately ₹2,34,10,00,00,000.00

What is the PE and PB ratio of Pfizer Ltd?

up
Pfizer Ltd Ltd's price-to-book ratio as of 15 Sep 2025 is 5.61, reflecting the market's valuation compared to its asset value. As of 15 Sep 2025, the trailing twelve months P/E (price-to-earnings) ratio is 30.83, indicating the market values the company at around ₹30.83 for every ₹1 of earnings

What is the 52 Week High and Low of Pfizer Ltd Share?

up
Pfizer Ltd Ltd (PFIZER) hit its 52-week high at ₹6,086.54, and its 52-week low at ₹3,718.77.
Begin your investment journey today
Login/Register
Start Now